PIK3CA hotspot mutations identified in CLVM vascular and lymphatic EC.... | Download Scientific Diagram
Low D2-40 immunoreactivity correlates with lymphatic invasion and nodal metastasis in early-stage squamous cell carcinoma of the uterine cervix | Modern Pathology
Lymph vascular invasion in invasive mammary carcinomas identified by the endothelial lymphatic marker D2-40 is associated with other indicators of poor prognosis | BMC Cancer | Full Text
D2-40 antibody immunoreactivity in developing human brain, brain tumors and cultured neural cells | Modern Pathology
Monoclonal Antibody D2-40, a New Marker of Lymphatic Endothelium, Reacts with Kaposi's Sarcoma and a Subset of Angiosarcomas | Modern Pathology
D2-40 immunohistochemical overexpression in cutaneous squamous cell carcinomas: A marker of metastatic risk - ScienceDirect
JDB | Free Full-Text | Genetic and Molecular Determinants of Lymphatic Malformations: Potential Targets for Therapy
Utility of D2-40, a novel mesothelial marker, in the diagnosis of malignant mesothelioma | Modern Pathology
Monoclonal Antibody D2-40, a New Marker of Lymphatic Endothelium, Reacts with Kaposi's Sarcoma and a Subset of Angiosarcomas | Modern Pathology
D2-40 immunohistochemical overexpression in cutaneous squamous cell carcinomas: A marker of metastatic risk - ScienceDirect
D2-40 antibody immunoreactivity in developing human brain, brain tumors and cultured neural cells | Modern Pathology
Characterization of patient-derived CLVM EC. a Western blot analysis... | Download Scientific Diagram
Monoclonal Antibody D2-40, a New Marker of Lymphatic Endothelium, Reacts with Kaposi's Sarcoma and a Subset of Angiosarcomas | Modern Pathology
Differential Diagnosis of Cystic Lesions of the Spleen: A Review of Clinical, Imaging and Pathological Findings - Bianca Puello Yocum, Michael Hwang, Hector Mesa, Katrina Collins, 2022
Utility of D2-40, a novel mesothelial marker, in the diagnosis of malignant mesothelioma | Modern Pathology
Lymph vascular invasion in invasive mammary carcinomas identified by the endothelial lymphatic marker D2-40 is associated with other indicators of poor prognosis | BMC Cancer | Full Text
A New Monoclonal Antibody, D2-40, for Detection of Lymphatic Invasion in Primary Tumors | Laboratory Investigation
Utility of D2-40, a novel mesothelial marker, in the diagnosis of malignant mesothelioma | Modern Pathology
D2-40 Antibody - Biocare Medical
Fibro-adipose vascular anomaly (FAVA): three case reports with an emphasis on the mammalian target of rapamycin (mTOR) pathway | Diagnostic Pathology | Full Text
Utility of D2-40, a novel mesothelial marker, in the diagnosis of malignant mesothelioma | Modern Pathology
Differential Diagnosis of Cystic Lesions of the Spleen: A Review of Clinical, Imaging and Pathological Findings - Bianca Puello Yocum, Michael Hwang, Hector Mesa, Katrina Collins, 2022
Sustainability | Free Full-Text | Critical Leaf Water Content for Maize Photosynthesis under Drought Stress and Its Response to Rewatering
Immunohistochemistry
Pica 521/40/SB Blister Permanent Marker Black | Bricoinn
Monoclonal Antibody D2-40, a New Marker of Lymphatic Endothelium, Reacts with Kaposi's Sarcoma and a Subset of Angiosarcomas - ScienceDirect
D2-40 (Lymphatic marker)
